184 related articles for article (PubMed ID: 12462386)
1. Mucinous cancers have fewer genomic alterations than more common classes of breast cancer.
Fujii H; Anbazhagan R; Bornman DM; Garrett ES; Perlman E; Gabrielson E
Breast Cancer Res Treat; 2002 Dec; 76(3):255-60. PubMed ID: 12462386
[TBL] [Abstract][Full Text] [Related]
2. Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH.
Aubele M; Mattis A; Zitzelsberger H; Walch A; Kremer M; Welzl G; Höfler H; Werner M
Int J Cancer; 2000 Jan; 85(1):82-6. PubMed ID: 10585588
[TBL] [Abstract][Full Text] [Related]
3. Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosity.
Smeds J; Wärnberg F; Norberg T; Nordgren H; Holmberg L; Bergh J
Acta Oncol; 2005; 44(1):41-9. PubMed ID: 15848905
[TBL] [Abstract][Full Text] [Related]
4. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
[TBL] [Abstract][Full Text] [Related]
5. Allelic loss of chromosomal arm 8p in breast cancer progression.
Anbazhagan R; Fujii H; Gabrielson E
Am J Pathol; 1998 Mar; 152(3):815-9. PubMed ID: 9502423
[TBL] [Abstract][Full Text] [Related]
6. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.
Larson PS; de las Morenas A; Cerda SR; Bennett SR; Cupples LA; Rosenberg CL
J Pathol; 2006 Jul; 209(3):307-16. PubMed ID: 16604511
[TBL] [Abstract][Full Text] [Related]
8. Breast carcinoma diverging to aberrant melanocytic differentiation: a case report with histopathologic and loss of heterozygosity analyses.
Nobukawa B; Fujii H; Hirai S; Kumasaka T; Shimizu H; Matsumoto T; Suda K; Futagawa S
Am J Surg Pathol; 1999 Oct; 23(10):1280-7. PubMed ID: 10524531
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
[TBL] [Abstract][Full Text] [Related]
10. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
[TBL] [Abstract][Full Text] [Related]
11. Patterns of chromosomal alterations in breast ductal carcinoma in situ.
Hwang ES; DeVries S; Chew KL; Moore DH; Kerlikowske K; Thor A; Ljung BM; Waldman FM
Clin Cancer Res; 2004 Aug; 10(15):5160-7. PubMed ID: 15297420
[TBL] [Abstract][Full Text] [Related]
12. Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization.
Gao Y; Niu Y; Wang X; Wei L; Lu S
J Mol Med (Berl); 2009 Feb; 87(2):145-52. PubMed ID: 18936904
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis of loss of heterozygosity in breast infiltrating ductal carcinoma distant normal tissue highlights arm specific enrichment and expansion across tumor stages.
Ruan X; Liu H; Boardman L; Kocher JP
PLoS One; 2014; 9(4):e95783. PubMed ID: 24748104
[TBL] [Abstract][Full Text] [Related]
14. Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer.
Loo LW; Ton C; Wang YW; Grove DI; Bouzek H; Vartanian N; Lin MG; Yuan X; Lawton TL; Daling JR; Malone KE; Li CI; Hsu L; Porter PL
Genes Chromosomes Cancer; 2008 Dec; 47(12):1049-66. PubMed ID: 18720524
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity and allelic imbalance in apocrine metaplasia of the breast: microdissection microsatellite analysis.
Selim AG; Ryan A; El-Ayat G; Wells CA
J Pathol; 2002 Mar; 196(3):287-91. PubMed ID: 11857491
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
Pan H; Califano J; Ponte JF; Russo AL; Cheng KH; Thiagalingam A; Nemani P; Sidransky D; Thiagalingam S
Cancer Res; 2005 Mar; 65(5):1664-9. PubMed ID: 15753360
[TBL] [Abstract][Full Text] [Related]
17. Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas.
Fujii H; Inagaki M; Kasai S; Miyokawa N; Tokusashi Y; Gabrielson E; Hruban RH
Am J Pathol; 1997 Nov; 151(5):1447-54. PubMed ID: 9358771
[TBL] [Abstract][Full Text] [Related]
18. Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization.
Ghazani AA; Arneson N; Warren K; Pintilie M; Bayani J; Squire JA; Done SJ
Neoplasia; 2007 Jun; 9(6):511-20. PubMed ID: 17603634
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity and microsatellite instability in ductal carcinoma in situ of the breast.
Ando Y; Iwase H; Ichihara S; Toyoshima S; Nakamura T; Yamashita H; Toyama T; Omoto Y; Karamatsu S; Mitsuyama S; Fujii Y; Kobayashi S
Cancer Lett; 2000 Aug; 156(2):207-14. PubMed ID: 10880771
[TBL] [Abstract][Full Text] [Related]
20. Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression.
Kittiniyom K; Gorse KM; Dalbegue F; Lichy JH; Taubenberger JK; Newsham IF
Breast Cancer Res; 2001; 3(3):192-8. PubMed ID: 11305954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
